Research & Development

New York University Study Finds Prominent Breakthrough for Pain Management; Outperforms Pain Drug

Researchers at New York University have made an important discovery in the field of pain management, revealing a potential paradigm shift. Their...

EnginZyme Utilizes Biocatalysis to Manufacture Essential Component for mRNA Vaccines

EnginZyme AB, a cutting-edge technology company specializing in enzymatic biomanufacturing, has successfully patented a revolutionary process for producing pseudouridine, a critical component...

Labcorp Unveils Breakthrough Blood Test for Alzheimer’s Diagnosis and Neurodegenerative Disease Detection

Labcorp has introduced a novel blood test aimed at aiding the diagnosis of Alzheimer's disease, further enhancing its range of services in...

Overcoming Age-Related Challenges in Nanodrug Delivery for Pediatric Cancer Patients

The efficacy of medical treatments often varies with age, and this principle holds true in the world of nanodrug delivery for pediatric,...

Promising BP-NELL-PEG compound may protect astronauts from rapid bone loss in space

After an unprecedented live return of mice from the International Space Station (ISS), the results were nothing short of astonishing. Soo, a...

Boston Scientific’s Farapulse System Irregular Heartbeat Treatment 

Boston Scientific, a pioneering force in medical technology, has revealed clinical data from a head-to-head trial that underscores the immense potential of...

Two-Year Study Shows Nevro’s High-Frequency Neurostimulation Reduces Diabetic Neuropathy Pain by 80%

Nevro's high-frequency neurostimulation system, after being granted FDA approval as the pioneering spinal cord stimulator to alleviate diabetic neuropathy pain, has received...

Takeda Pulls Application For Dengue Vaccine Qdenga

Travelers and medical professionals from the U.S. who are hoping for a different, maybe safer, dengue vaccination will have to wait. 

Latest news

Merck’s Evobrutinib Encounters Setbacks in MS Trials Amid BTK Inhibitor Challenges

Merck KGaA's foray into the competitive BTK inhibitor space has hit a roadblock, with its highly-touted contender,...

Lilly’s Jaypirca leads the leukemia trail with FDA approval

In the highly competitive landscape of BTK inhibitors for blood cancer treatment, Eli Lilly has set itself...

Merus Faces Setback Following Interim Report for Lung Cancer Therapy

Merus, a biopharmaceutical company, confronted a significant setback following an interim report on the progress of MCLA-129,...

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

You might also likeRELATED
Recommended to you

GSK collaborates with Chinese giant Zhifei on a $3 billion Shingrix project

GSK has established a strategic partnership with...

Amgen Cuts Lupus Programs Along with Lilly

Amgen has discontinued both of its mid-stage...